WX-UK1

WX-UK1 · Heidelberg Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WX-UK1, covering 2008-01-24 to 2008-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Urokinase-Plasminogen Activator (uPA) Inhibitor WX-UK1 in Combination With Capecitabine in Advanced Malignancies [Phase 1]

See pricing